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Yorpy principle 
I suspect there are very fcw of us who stem from 
the New England coastline who haven't harbored the 
thought, however misguided, of  going to sea for 
some protracted time. The rationale underlying this 
aberrant behavior is as varied as those contemplating 
such foolishness, but a common denominator con- 
sists of  an escape from some magnitude of  pain 
inflicted by circumstances seemingly be ond one's 
control. It takes a good deal more pain for some than 
others to resort o this desperate measure ven today, 
but imagine doing so 150 years ago. The exhilaration 
of sailing among humpbacks on Stelwagon Bank or 
rounding Cross Rip Shoal eastbound for Nantucket 
with both Cape Pogue and Great Point visible belies 
the potential hostility of  an ill wind and an angry sea. 
The relative safety of modern hull and sail design, 
coupled with the reliability of auxiliary power and 
satellite navigation systems, has eliminated a good 
deal of  the uncertainty facing our ancestral mariners. 
Going to sea for a properly bred New England lad in 
the early 1800s would mean accepting a commission 
in the U.S. Navy, a fially approved avocation. Another 
option, frowned upon by the puritanical Brahmin, 
required signing on in the whaling industry with 
such inherent errors as tumbling out of ice-encrust- 
ed mastheads, uccumbing to the flukes during the 
chase and suffering the indignities of  the fo'c'sle 
under an unprincipled master. The voyages were typ- 
ically a lengthy 3 to 4 years, and most whalemen 
returned not a penny the wealthier, but having had a 
semblance of room and board for the interim. 
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Fig. 1. Illustration by Rockwell Kent from Moby Dick, 
Random House, New York, 1930. 
On Christmas Day, 1840, a young man of  21 
years signed aboard a newly built whaling vessel reg- 
istered in Faithaven, Massachusetts. The Acushnet 
slipped its moorings a week later on the third of  
January, 1841, and as she fetched Buzzard's Bay 
with New Bedford fading from view, he was able 
to escape his perceived torment,  which derived 
from an overbearing Calvinistic mother, the self- 
inflicted death of  his father, and a lifetime of  
parental dotage on his older brother. Who would 
have imagined as the topsails were set and 
trimmed on that frigid January morning that this 
young adventurer would return four years later 
and, with explosive imagination, embellish is voy- 
age in a rather lengthy novel. The first sentence of  
that novel read, "Call me Ishmael"; the author, my 
great-great grandfather. 
Paradoxically, that sentence turns out to be 
among the shortest Melville crafted, and though we 
undoubtedly share some common nucleic acid 
sequences, I claim absolutely no responsibility for 
the run-on sentence nor for the cruel and unusual 
punishment inflicted on junior high school readers 
by overly zealous teachers of American literature. 
Even as a member of the family, I can assure you that 
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neither the Classics Illustrated comic series or Cliffs 
notes were lost on us, but having plowed through 
Moby Dick under duress at a tender age, I conclud- 
ed at the very least, that if you arc indeed going to 
chase white whales, better to do so with two legs 
rather than one! The influence of this conclusion on 
my subsequent career choice is at least intriguing. 
Melville was born on August 1, 1819, on Pearl 
St. on New York City's Lower West Side as the third 
of ultimately eight children.l,2 As it turns out, he was 
delivered on that humid August evening by none 
other than Dr. Wright Post, a well-known obstetri- 
cian and professor of anatomy and physiology at the 
College of Physicians and Surgeons, whose contri- 
bution to the literature was titled "The Ligation of 
Iliac Artery Aneurysms." It's hard to know how 
the American Board of Surgery would react to 
his quest for certification today. Melville's mother, 
Marie Gansevoort, was the granddaughter of Peter 
Gansevoort, a general in the Revolutionary Army 
who successfully held Fort Schuyler near Albany 
against he advancing British troops. From strong 
Dutch-Calvinistic principles, Marie was a powerful 
match for her husband, Alan Melville, the grandson 
of Major Thomas Melville, also a Revolutionary War 
figure in Boston whose prominence as a Mohawk 
during the Tea Party inspired Oliver Wendell Holmes 
to write the poem titled "The Last Leaf" com- 
memorating his death. Between mother Melville's 
Calvinism and father Alan's puritanical leanings, tittle 
wonder that Herman fled to the waves. 
Interestingly enough, Melville's performance dur- 
ing his early education was less than stellar in contrast 
to his older brother, Gansevoort, who was a shining 
example of academic prowess. Both attended the well- 
known New-York Male High School in Manhattan, 
noted for its policy of materially rewarding scholarly 
performance while deliberately inflicting guilt and 
shame on the underachiever. Herman was described as 
"very backward in speech and somewhat slow in com- 
prehension, "z undoubtedly the expression of one of 
those few DNA sequences we share. Eventually he 
came into his own in Albany and following graduation 
and his father's death, he was appointed to a variety of 
teaching posts, none of which proved particularly 
durable. During the Depression of 1837, Melville 
fotmd himself seeking the financial security of what 
appeared to be an open market in surveying and engi- 
neering. In November of 1838, he received his certifi- 
cate from Lansingburgh Academy but shortly became 
disillusioned when even these positions proved scarce. 
It was at this point that he chose to sign on for the 
well-known whaling voyage. 
After 18 months aboard the Acushnet under the 
sadistic Captain Pease, Melville and a shipmate, 
Toby Greene, jumped ship to spend the next four 
weeks in the Marquesas I lands. The native islanders, 
widely perceived as cannibals, in truth belonged to 
the peace-loving Typee tribes. For the first time, 
Melville had solid evidence contrary to the conven- 
tional belief that such native individuals represented 
the devil reincarnate, a belief widely used to justify 
the atrocities he witnessed at the hands of visiting 
European and American maritime communities. His 
peaceful experience among the islanders reinforced 
Melville's characteristic willingness, if not compul- 
sion, to intellectually challenge established dogma. 
In August of 1842, Melville signed on the Lucy 
Ann, a whaler with a particularly disgruntled crew 
that threatened mutiny shortly after arriving in 
Tahiti six weeks later. Because Herman was sympa- 
thetic to the crew, he and ten others were off-loaded 
in leg irons and imprisoned on the island. The prison 
proved "free and easy" allowing him to come and go 
nearly at will, and in November, Melville secured a
berth on the Charles and Henry, a whaler out of 
Nantucket bound for Hawaii. After 5 months 
Melville was a free man on Maui, and after traveling 
to Honolulu, he found employment setting up 
pins in a bowling alley and then as a clerk for 
Montgomery's. He became progressively unpopu- 
lar, however, because of his views against both color 
nialism and slavery, so much so that he ultimately 
signed aboard the flagship of the Pacific Fleet, the 
U.S.S. United States, as an enlisted able-bodied sea- 
man. Although this was a four-year enlistment, 
Melville was released at the end of the voyage in 
1844 in Boston, discharged with the first dollars in 
his pocket he had seen in four years. 
After rejoining his family, Melville set about the 
task of drawing on his experiences and by the spring 
of 1847 he had published his first two novels, Typee 
and Omoo, essentially travel novels very much in fash- 
ion at the time. Because of inadequate copyright pro- 
tection in the United States, he published simultane- 
ously in London and New York, both to positive crit- 
ical reviews. Buoyed by his initial success, Melville 
married Elizabeth Shaw, the daughter of Judge 
Lemuel Shaw of Boston. Lizzy and Herman lived the 
rest of their lives shuttling between Manhattan and 
Albany in New York and Pittsfield, Massachusetts. It 
was in Pittsfield that the Melvilles purchased the farm 
they later named Arrowhead and settled into what 
must have been an extraordinary intellectual environ- 
ment. Melville's closest friends included Emily 
Sedgewick, Henry Thoreau, Oliver Wendell Holmes 
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and, most importantly, Nathaniel Hawthorne, twelve 
years his senior. In this environment, Melville com- 
pleted his next three novels, Redburn, White-Jacket 
and Mardi, each addressing controversial issues and 
each provoking conflicting reviews. 
Melville suffered from many afflictions during 
his life, among them probably alcoholism and 
manic-depressive episodes, which wreaked serious 
havoc with the domestic tranquility and nearly cost 
him his family on at least one memorable occasion. 
He most definitely experienced severe bouts of sciat- 
ica, for which Holmes frequently prescribed a com- 
pound consisting of arsenic, morphine, opium, 
ammonia, turpentine, potassium iodide, tincture of 
aconite, and belladonna. 2 It is difficult o ignore the 
potential effect of this concoction on his behavior! 
Melville probably began work on Moby Dick 
during the hot summer of 1850 in New York City, 
but it was at Arrowhead during the following 
spring that The Whale was largely written. Its cre- 
ation was one of constant revision; even as the first 
chapters were coming off the press, the last were 
being written and then transcribed into fair copy by 
Lizzy. Melville dedicated the novel to Nathaniel 
Hawthorne, certainly a tribute to his friend's intel- 
lect but also to Hawthorne's teadfast faith in his 
literary talent, a faith that provided that critical 
nurturing influence often so important for the 
truly innovative. During his lifetime, Melville 
received a little over $1200 for Moby Dick, and 
Lizzy another $600 following his death. 
Melville published Moby Dick in 1851 at the age 
of 31, when his life was not half spent, for he died at 
72, a U.S. Customs Inspector in New York City. The 
latter half of his life remained evoted to letters, and 
during thc initial few years he wrote several short 
stories for Harper's Monthly and Putnam's. He then 
became increasingly preoccupied with poetry, much 
of which has not been widely publicized, and some 
of which is probably good. It is his short stories, 
however, to which I would draw your attention, 
always insightful with respect o human behavior 
and many quite entertaining. I should like to men- 
tion one in particular entitled "The Happy Failure," 
published in Harper's in 1854. This is a wonderful 
tale of an elder inventor, his Dutch-African manser- 
vant, Yorpy, and his nephew, who narrates the events 
on the day his uncle unveiled the results of his ten- 
year quest for a recognized invention. 
The story centers on a variety of observations 
made during a journey that required Yorpy and the 
nephew narrator to pull at the oar ten miles up the 
Hudson River to Quash Isle, the test site for the 
invention. The creation was called "The Great 
Hydraulic-Hydrostatic Apparatus" for draining 
swamps and marshes. The narrator efers to this 
device, which was housed in a coffin-like box, as 
looking like a "huge nest of anacondas and adders." 
The invention of course fails irreverently and the iras- 
cible inventor becomes predictably angry and morose 
during the return trip downstream. As he reflects on 
his efforts, however, his anger eventually succumbs 
to an appreciation f the chase and a sense of relief 
from the intense burden as he admits to his nephew, 
"I say, boy, failure has made a good old man of me." 
He is finally able to express his true gratitude for 
Yorpy's steadfast upport, to which Yorpy responds," 
I tank yoo, dear old massa; I tank you so kindly. Yoo 
is yourself again in de ten long 'ear. Old massa then 
replies, "Praise be to God for the failure." 
So the gospel according to Yorpy implies steadfast 
support of the creative mind most importantly during 
the developmental phases of an idea that knowledge- 
ably may or may not prove successful in the end. What 
the inventor is trying to convey is an appreciation for 
the opportunity to participate in the effort, and for 
the sense of relief at conclusion, be the result positive 
or negative. And herein lies my concern. We have 
become so attuned to the expectation of success that 
I perceive we arc very much in danger of losing our 
collective intellectual curiosity, which requires both a 
willingness to fail and a support mechanism to do so. 
All of us in this room have had some fascinating ideas 
at one time or another and some of them probably 
very good. You heard Dr. Victor Dzau in the Linton 
Address describe our ongoing effort to utilize princi- 
ples of gene therapy in humans to optimize infrain- 
guinal reconstruction. It would be unrealistic f any of 
us denied the possibility that this initial attempt may 
in fact fail miserably. You also heard Dr. Juan Parodi 
give the Distinguished Lecture describing the evolu- 
tion of the cndovascular pproach to the management 
of ancurysms, an evolution that encompasses both 
success and failure, testimony to the perseverance of
the investigator. 
I had the distinct privilege of working with Art 
Voorhees during my residency and John Mannick for 
most of my career, and there are many others, some 
with us today, who share the same nurturing qualities 
that facilitate support for the curious mind. Art had a 
way of stimulating the imagination f those around 
him, and at one point I was following some of his 
pediatric patients who had undergone portocaval 
shunts for biliary cirrhosis. Of sixteen children, all 
but one had serious neuropsychiatric derangement, 
and of eight with normal liver function, five were 
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institutionalized for emotional disorders. Art pointed 
out that many of these children carried the diagnosis 
of chronic undifferentiated schizophrenia. 3 I had the 
slightly deviant thought that perhaps ome portion of 
the metabolic derangement resulting from portosys- 
temic diversion might alter cerebral metabolism suf- 
ficiently to produce a common denominator under- 
lying schizophrenic behavior. 
As I began to uncover the facts, a study carried 
out following the deaths of fifteen inmates from a 
mental hospital in Denmark demonstrated a dispro- 
portionately high incidence of spontaneous portacav- 
al shunts. 4 Congenital shunts are lmown to be hemo- 
dynamically significant and to produce encephalopa- 
thy to varying degrees.a, 6 During that same year, I 
came across a fascinating patient at the Neurologic 
Institute whose vocation as a local postal worker was 
normally unfailing. 5 At times, however, his behavior 
became so strange that his wife would refuse to allow 
him in the house, and he intermittently transformed 
the telephone booth outside the hospital into a very 
public restroom. He eventually underwent a workup 
at the Neurological Institute in New York, where his 
metabolic encephalopathy, in spite of normal liver 
function, prompted an ammonia tolerance test and a 
subsequent splenoportogram that documented a 
congenital intrahepatic portocaval fistula. His intra- 
hepatic fetal portosystemic circulation was partially 
preserved, and as such he was subject o meat intox- 
ication. These considerations initiated my proposal to 
Art that we protein load some inmates at the 
Manhattan State Psychiatric facility on Ward's Island 
and then measure their ammonia levels, essentially an 
ammonia tolerance test. 
While it was certainly I who traipsed out to New 
York State Psychiatric Institute on Ward's Island on 
a weekly basis and traded blood samples for ciga- 
rettes, it was Art who came up with the money and 
moral support to keep the project going long 
enough to discover that we were not able to suc- 
cessfully load our patients with enough protein 
before they became quite ill and failed to show up 
for testing. During my subsequent years under John 
Mannick, I was able to participate in the hybrid arti- 
ficial pancreas project at the Joslin Clinic7, 8 and 
designed the rodent and canine implant models. We 
developed an endothelial seeding capability in our 
lab at the Brigham 9and explored the fanciful notion 
of an autogenous prosthesis, l° Eight hours after 
canine or human vascular smooth muscle cells were 
placed in a solution of collagen in a Kimax tube, the 
cells organize the precipitating f brils around the 
central glass mandril to create a tubular structure, 
which, in turn, was fined with autogenous endothe- 
lium. These bioprosthetic grafts were then implant- 
ed into dogs with patency sustained for at least the 
short term. We have since participated in several 
genetic experiments, l l  some of which you heard Dr. 
Dzau discuss. Although I personally have not man- 
aged to come up with the panacea for intimal hyper- 
plasia or the elusive biocompatible synthetic sub- 
strate, at least I have been able to participate in the 
great chase and in so doing contribute to our collec- 
tive knowledge base. 
It is this opportunity to chase our own individual 
white whales about which I continue to express my 
concern, a concern that derives from a number of 
ominous and interrelated trends. The overall reduc- 
tion in clinical revenues, in spite of increasingly aus- 
tere operating budgets, has all but removed funds 
derived from reimbursement previously available for 
research and education. Substantial allocations for 
research from our own surgical group have dimin- 
ished some 80% during the past four years, and the 
trend is similar nationwide. This trend appears irre- 
versible as we face a 9% reduction in Medicare reim- 
bursement in 1998 and anticipate a further 10% to 
I5% reduction by the year 2001 from the practice 
expense component. 
The Brigham and Womens Hospital, known for 
major contributions from its full-time faculty, can no 
longer subsidize research space. Each clinical depart- 
ment is responsible for an annual charge approach- 
ing $200 per square foot, and the ability for a clini- 
ca/ surgeon to cover an annual indirect charge of 
$300,000 for a freestanding wet lab of i500 square 
feet is far from a foregone conclusion. Even a small- 
er 500 square foot space dependent upon core labo- 
ratory facilities requires an annual commitment of 
$100,000, which if not met by the individual inves- 
tigator must be assumed by the department, an 
obligation ot met with great enthusiasm by most 
surgical chairs. 
Federal dollars awarded through the National 
Institutes of Health to young vascular surgeons have 
become increasingly scarce for a variety of reasons, 
not the least among them an inability to commit sig- 
nificant blocks of time in the lab because of clinical 
demands. Congress has also threatened to restrict 
reimbursement to hospitals for resident training to a 
maximum of five years. This threat in part prompted 
the American Board of Surgery to delete the one- 
year credit previously granted to residents for non- 
surgical pursuits and most often used for training in 
basic investigative t chniques. Medical student debt 
incurred to pay for educational expenses became 
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increasingly difficult to repay, particularly with rela- 
tively low salaries and miserable work hours, 
Managed care with its inherent emphasis on clin- 
ical efficiency probably poses the single most omi- 
nous threat o scientific medical progress. A tightly 
managed nonprofit HMO is threatening enough 
because of rigorous cost control and demands for 
clinical productivity, but consider the impact of for- 
profit organizations. In the October 14, 1996, issue 
of Fortune, Oxford Health Plans ranked number five 
among America's fastest growing companies with an 
annual growth rate of 130% associated with a per 
share annual growth of 77%. The total compensa- 
tion packages of the CEOs of the two largest not- 
for-profit HMOs in Boston approached $900,000 in 
1994, but this figure pales against the sums of 
$2,589,000 and $2,493,000 received for 1996 by 
the CEOs of Aetna and Cigna, respectively, both 
for-profit enterprises. Place these sums in juxtaposi- 
tion to the fact that the total number of health care 
administrators has increased by 692% during the past 
twenty-five years, which incrcases the proportion of 
such individuals to 27% of the total healthcare work 
forcc) 2 A recent study by Moy and associates 13
sponsored by the Association of American Medical 
Colleges, confirmed the negative impact of managed 
care on the number of NIH grants awarded to U.S. 
medical schools. While comparable rates of growth 
were observed in all markets through 1990, subse- 
quent growth both in numbers and amounts of 
awards was significantly slower for schools ubjected 
to high levels of managed care penetration. 
Characteristic of the macroeconomics during the 
1980s, stocldlolders were expectant of high short-term 
gains, and industry was not interested in funding any 
project that could not be turned into bottom-line 
profit within two years. Hence, research investigations 
of endothelial seeding of otherwise incompatible bio- 
substrates or autogenous arterial substitutes were out 
of the running because both represent long-term 
endeavors. David Blumenthal and colleagues 14recent- 
ly reported in the New England Journal of Medicine 
results ~om their survey of 210 life-sciences companies 
designed to assess the impact of industrial support for 
university-based research. Nearly 60% provided some 
level of support, yet their aggregate contribution 
accounted for only 12% of all research-and-develop- 
ment dollars received. The authors concluded that 
such industrial sources tend to be of short duration, 
confirming the perceived necessity for short-term 
profiteering, and will not provide significant compen- 
sation for federal reductions. 
The aggregate reduction in both time and funds 
;7 'i 
Fig. 2. Herman Melville, 1870. Portrait by Joseph Oriel 
Eaton on loan to Houghton Library, Harvard University. 
available has placed in serious jeopardy the sustained 
ability of surgeons to participate in significant inves- 
tigative efforts and therefore to realistically compete 
for federal funding. In response to these trends, the 
academic ommunity, including Harvard Medical 
School, has established alternative tracks for promo- 
tion that do not require basic science productivity or 
even clinical investigations, a development that I 
fully endorse as a practical necessity but one that 
preys further on the motivation ofyoung minds. 
While there have been innumerable advances 
that have matured our specialty, I have singled out 
three that have significantly improved care for 
patients with vascular disease and that were initially 
developed in the absence of formal financial support 
to illustrate the necessity for careful stewardship on 
the part of our surgical eadership in identifying 
younger individuals with initiative and intellectual 
curiosity as yet unencumbcred by either profound 
historical knowledge or by years of experience. 
Melville would have been proud of this paragraph-- 
a single run on sentence! 
In 1948, after an internship at Columbia- 
Presbyterian Medical Center and prior to his depar- 
ture for military duty at Brooke Army, Art Voorhees 
exhibited those qualities as a research fellow working 
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Fig. 3. Illustration by Rockwell Kent from Moby Dick, 
Random House, New York, 1930. 
in the laboratory of his chief, Arthur Blakemore. 
Blake charged Art with developing a suitable replace- 
ment for the mitral valve. During an explant of a 
canine prototype, a silk suture that had become com- 
pletely covered by endocardium caught Art's eye. 
His wife, Mags, recalls that he borrowed, on a per- 
manent basis, one of her silk handkerchiefs that he 
then transformed into a textile arterial prosthesis on 
her vintage Necchi sewing machine. The first canine 
implant resulted in exsanguination after an hour, yet 
another happy failure. Subsequent canine implants, 
however, with tubes fashioned from silk handker- 
chiefs and neckties affirmed Blakemore's faith in 
Art's endeavors and resulted in his providing Art 
with seed money derived from the infamous "Fund 
for the Advancement of Blood Vessel Surgery." 
During the following two years in the Army, Art 
was able to further his concept, employing retired 
members of the canine corps and nylon, a relatively 
new parachute material. Upon Art's return to 
Presbyterian i 1950, Vinyon-N was available, and 
after some thirty implants, the data for the landmark 
paper was complete. 1s-is After many late-night dis- 
cussions with William Leibig, who lived in the same 
town in New Jersey, Art convinced Blake to purchase 
for $5000 a textile knimng machine from Germany. 
Housed in a small shed on the Connecticut River, 
they established an embryonic graft manufacturing 
plant. Not unlike the experience portrayed in 
Melville's "Happy Failure," the shed and its inanimate 
contents were unceremoniously swept away by a par- 
ticularly ill-timed hurricane. Fortunately, through 
Art's perseverance and Blake's somewhat elusive but 
seemingly inexhaustible Fund, the modern arterial 
prosthesis evolved. The primary source of Blake's 
funds derived from grateful patients from downtown 
Manhattan, very little from industry, and virtually 
none from federal sources. 
Tom Fogarty, while a student in high school, 
worked as a scrub technician and subsequently 
assisted Jack Cranley regularly during his premedical 
and medical school years. Motivated by the extraor- 
dinary morbidity associated with peripheral arterial 
occlusion, Fogarty began as a medical student o 
develop the embolectomy catheter with bits and 
pieces of equipment that he "borrowed," albeit with 
little intention to return, as he resorted to the "pack- 
rat" technique well known to most of us who have 
harbored fledgling ideas. The first prototype was 
born from a 6 French ureteral catheter and the little 
finger from a size 5 latex glove tied to the tip of the 
catheter with fly-fishing technique. 19 Shortly there- 
after Tom was given a berth in Bert Dunphy's pro- 
gram at the University of Oregon, where he tested 
these hand-fashioned catheters in two cadavers. 
Although Fogarty was drafted for military duty after 
his internship, his induction papers were inadver- 
tently misplaced. This fortuitous error enabled him 
to spend most of 1961 with Jack Cranley, during 
which time the first clinical catheter embolectomy 
was carried out. Tom recognized the need and con- 
ceived the solution, and thanks to his perseverance 
brought his concept to clinical fruition without 
structured financing. 
During 1968, shortly after joining the faculty at 
the University of Oklahoma, Lazar Greenfield began 
work on a pulmonary embolectomy catheter with 
some ill-defined start-up funds from his chairman, 
John Schilling. Greenfield collaborated with a bril- 
liant petroleum engineer, Garman Kimmel, with 
whom he had worked at Hopkins in developing a
device to measure surface tension. While early results 
with pulmonary embolectomy were not entirely dis- 
couraging, the incidence of recurrent pulmonary 
emboli was far from insignificant. Lazar recognized 
the flaws inherent in the Mobin-Uddin vena cava 
umbrella and set out to develop a new approach. 2° 
The petroleum industry used a cone-shaped filter 
device to prevent he accumulation of sludge on 
valves along pipelines, and an adaptation of that basic 
principle became the first Kim-Ray Greenfield IVC 
filter. Once again, at its inception, there were no spe- 
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cific funds for this project, which depended upon 
seed money provided by an academic chairman and 
ultimately venture capital for commercial scale-up. 
While there are ample grounds to justify the fear 
that further innovation within our specialty is in jeop- 
ardy, all is far from lost. I have attempted to illustrate 
our independence from federal sources in supporting 
truly significant contributions to our field in an effort 
to encourage our surgical leadership to excrcise the 
full range of stewardship with which they have been 
entrusted. To focus on the diminishing funds avail- 
able from the N IH  and Health Care Financing 
Administration for young investigators in vascular 
surgery and retreat into investigative complacency is 
perhaps the path of least resistance and all too easily 
justified by the clinical demands of  our current med- 
ical economic system. Yet we need to carefully iden- 
tify those individuals with the intellectual initiative 
and characteristic perseverance necessary for inves- 
tigative careers. To do so will require that opportuni- 
ties be provided for all those potentially interested to 
participate in that process of identification. As 
implied by Melville's Yorpy, those opportunities must 
of necessity ield many failures, but will also enable, 
albeit far less frequently, significant progress. 
While these opportunities may bc fotmd in estab- 
lished laboratories, increasingly maintained by senior 
investigators in related but nonsurgical disciplines, 
we must look diligently for alternative sources. 
Educational grants from industry arc probably most 
useful for short-term seed money but must not carry 
strings attached that compromise academic integrity. 
Philanthropic funds can be more fully tapped, and 
support is increasingly available through Society 
sponsored sources such as our own Lifeline Found- 
ation, now able to provide an annual $50,000 grant 
for each of two years to young surgical investigators. 
The American College of  Surgeons, National and 
Affiliate chapters of the American Heart Association, 
and local medical school sources are also available. 
Finally, there is the wealthy grateful patient who has 
played a significant but frequently underestimated 
role in supporting surgical research. 
It has been an extraordinary honor to have 
served as an officer and your president this past year, 
and I am truly grateful for the opportunity you have 
given me to express these thoughts. While it is true 
that most vascular surgeons can no longer realistical- 
ly maintain expertise in all aspects of  scholarly med- 
ical endeavor, I firmly believe that everyone deserves 
the chance to find that out for themselves at an early 
stage with an unencumbered yet energetic and 
inquisitive mind. In so doing, young vascular sur- 
geons will perceive their own unique white whales 
and thereby continue to make significant contribu- 
tions in concert with the gorpy principle. 
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